What is Theranostics?
Theranostics is a new field of medicine which combines specific targeted therapy based on specific targeted diagnostic tests.
A specific diagnostic test shows a particular molecular target on a tumour, such as the PSMA receptor in prostate cancer. This allows a therapy agent, such as Lutetium-177 PSMA, to specifically target that receptor on the tumour.
Moving away from the one medicine fits all approach to offering the right treatment, for the right patient, at the right time with the right dose, provides more targeted, efficient pharmacotherapy in the form of theranostics.
For more information, visit www.theranostics.com.au